#RSVprevention
LightNews LightNews
aclamo.bsky.social
This season, protect yourself and your loved ones from Respiratory Syncytial Virus! RSV can cause serious respiratory illness, especially in young children, older adults, and those with weakened immune systems.

#ACLAMO #RSVPrevention #Vaccination #StayHealthy #ProtectYourFamily #RSVAwareness
January 24, 2025 at 2:49 PM
accesspress.org
Baylor College of Medicine reports that the implementation of new #RSV prevention strategies, including maternal vaccination and infant antibody treatments, has led to a significant reduction in hospitalizations among infants aged 0–7 months.

#AccessPress #BaylorCollegeOfMedicine #RSVPrevention
For the first time there are safe and effective RSV prevention treatments and they significantly reduce hospitalizations in infants
Respiratory syncytial virus (RSV) is the number one cause of hospitalization in infants, accounting for about 25% of all their hospitalizations. However,...
buff.ly
June 3, 2025 at 5:05 PM
nmqf.bsky.social
RSV season is coming. Parents can prepare before illness strikes by knowing who is most vulnerable, understanding prevention options and recognizing warning signs of serious illness.

Access to RSV protection matters, too.

Read more: fyh.news/rsv-season-p...

#RSV #RSVPrevention #NMQF
September 22, 2026 at 3:12 PM
bionewscentral.com
#Immunization with #nirsevimab, a long-acting #antibody, protected #infants against #RSV and sharply reduced #hospitalizations and #ICU admissions.
#RSVprevention
Immunization to prevent RSV in infants reduced ICU admissions by 97 percent – BioNews Central
Immunization with nirsevimab, a long-acting antibody, protected infants against RSV and sharply reduced hospitalizations and ICU admissions. ...
sbee.link
September 15, 2026 at 8:28 PM
wtfwire.bsky.social
Prepare for the 2025-26 #respiratoryvirusseason. Learn who should get vaccinated against Covid-19, flu, and RSV, where to get shots, and the best timing. #WTFWire #FluShot #RSVVaccine #HealthAwareness #Immunization #FluSeason2025 #Covid19Prevention #RSVPrevention www.wtfwire.com/health/2025-...
WTF Wire
October 20, 2025 at 9:41 AM
nmqf.bsky.social
🔵 Today is the day!
There’s still time to join us LIVE for a critical conversation about protecting newborns from RSV.

📅 TODAY — Nov. 21
⏰ 12 PM ET / 9 AM PT
🔗 Register & Join Live: bit.ly/NMQF1121

#RSV #RSVPrevention #MaternalHealth #InfantHealth #HealthEquity #NMQF #SHC #NewbornCare
November 21, 2025 at 2:27 PM
nmqf.bsky.social
We’re just two days away from a powerful discussion on newborn health and RSV prevention.

Join us!
📅 Friday, Nov. 21
⏰ 12 PM ET / 9 AM PT
🔗 Register: bit.ly/NMQF1121

Don’t miss it! 💙🍼

#RSV #RSVPrevention #InfantHealth #MaternalHealth #HealthEquity #NMQF #SHC
November 19, 2025 at 3:01 PM
nmqf.bsky.social
🚨 Happening This Friday! 🚨

A Safe Start for Every Baby:
What Every Parent, Clinician, Hospital, and Payer Should Know About Preventing RSV in Newborns

📅 Friday, Nov. 21
⏰ 12 PM ET / 9 AM PT
🔗 Register: bit.ly/NMQF1121

#RSV #RSVPrevention #MaternalHealth #InfantHealth #NMQF #SHC #NewbornCare
November 17, 2025 at 8:36 PM
xstreamfm.bsky.social
AL. State Agencies:Alabama News Beacon #RSVPrevention #Beyfortus #MonoclonalAntibody #InfantHealth #FDAApproval
RSV Prevention Criteria for the 2023–2024 Season
[Medicaid] • Beyfortus (nirsevimab), a long-acting monoclonal antibody product, was approved by the US Food and Drug Administration (FDA) on July 17, 2023, for use in newborns and infants to protect against (medically attended) respiratory syncytial virus (RSV).1
dlvr.it
July 6, 2025 at 5:50 AM
4040rec.bsky.social
#Enflonsia #RSVprevention #Clesrovimab #monoclonalantibody #MHRA #MSD #respiratorysyncytialvirus #RSV #RSVseason #RSVnationalimmunisationprogramme #Paediatrics #neonatology #monoclonalantibodyprophylaxis #RSVdisease #CLEVERclinicaltrial #NEJM
zurl.co/toqIz
UK medicines regulator grants marketing authorisation to Enflonsia for RSV prevention - PharmaTimes
Clesrovimab is first monoclonal antibody offering a single fixed dose for infants
pharmatimes.com
April 28, 2026 at 8:22 AM
4040rec.bsky.social
#Abrysvo #Pfizer #WHO #WorldHealthOrganization #maternalRSVvaccine #RSVprevention #respiratorysyncytialvirus #RSV #RSVvaccine #prequalifiedvaccines #RSVinfection #maternalvaccination #GAVI #Unicef #publichealth #passiveimmunisation
pharmatimes.com/news/who-add...
WHO adds first maternal RSV vaccine to prequalification list - PharmaTimes
Pfizer’s Abrysvo is designed to prevent RSV-associated disease in infants
pharmatimes.com
March 26, 2025 at 11:15 AM
mdspirenews.bsky.social
A recent study reveals that the new RSV vaccine is 91% effective in preventing hospitalizations and emergency department visits among adults 60+ at increased risk. This large-scale analysis underscores its potential in reducing severe RSV-related illness. #RSVPrevention #MedicalResearch
New Vaccine Prevents Severe RSV Illness
A recent study showed the new vaccine was more than 90% effective in the prevention of hospitalizations and emergency department visits due to RSV among those 60 years old or older.
conexiant.com
December 13, 2024 at 7:45 PM